ArticleOncogenesis2018

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma.

Marta Di Martile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.